Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

U S Global Investors (GROW) Cash & Equivalents (2016 - 2025)

U S Global Investors' Cash & Equivalents history spans 16 years, with the latest figure at $1.0 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 96.16% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.0 million, down 96.16%, while the annual FY2025 figure was $1.0 million, 96.35% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $1.0 million at U S Global Investors, down from $24.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $27.5 million in Q4 2023 and bottomed at $1.0 million in Q2 2021.
  • The 5-year median for Cash & Equivalents is $1.0 million (2021), against an average of $11.3 million.
  • The largest annual shift saw Cash & Equivalents skyrocketed 2646.6% in 2023 before it crashed 96.36% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $1.0 million in 2021, then changed by 0.0% to $1.0 million in 2022, then surged by 2646.6% to $27.5 million in 2023, then fell by 5.19% to $26.0 million in 2024, then plummeted by 96.16% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for GROW's Cash & Equivalents are $1.0 million (Q4 2025), $24.6 million (Q3 2025), and $1.0 million (Q2 2025).